BioRem Inc.
BioRem Inc. Fundamental Analysis
BioRem Inc. (BIRMF) shows strong financial fundamentals with a PE ratio of 10.78, profit margin of 11.37%, and ROE of 39.50%. The company generates $0.0B in annual revenue with strong year-over-year growth of 48.69%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 76.6/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze BIRMF's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBIRMF demonstrates superior asset utilization.
Valuation Score
ExcellentBIRMF trades at attractive valuation levels.
Growth Score
ExcellentBIRMF delivers strong and consistent growth momentum.
Financial Health Score
ExcellentBIRMF maintains a strong and stable balance sheet.
Profitability Score
ModerateBIRMF maintains healthy but balanced margins.
Key Financial Metrics
Is BIRMF Expensive or Cheap?
P/E Ratio
BIRMF trades at 10.78 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, BIRMF's PEG of 0.14 indicates potential undervaluation.
Price to Book
The market values BioRem Inc. at 3.48 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 8.55 times EBITDA. This is generally considered low.
How Well Does BIRMF Make Money?
Net Profit Margin
For every $100 in sales, BioRem Inc. keeps $11.37 as profit after all expenses.
Operating Margin
Core operations generate 15.60 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $39.50 in profit for every $100 of shareholder equity.
ROA
BioRem Inc. generates $14.35 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
BioRem Inc. produces operating cash flow of $7.63M, showing steady but balanced cash generation.
Free Cash Flow
BioRem Inc. generates strong free cash flow of $7.26M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.45 in free cash annually.
FCF Yield
BIRMF converts 14.02% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
10.78
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.14
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.48
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.22
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.19
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.85
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.40
vs 25 benchmark
ROA
Return on assets percentage
0.14
vs 25 benchmark
ROCE
Return on capital employed
0.39
vs 25 benchmark
How BIRMF Stacks Against Its Sector Peers
| Metric | BIRMF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 10.78 | 26.49 | Better (Cheaper) |
| ROE | 39.50% | 1280.00% | Weak |
| Net Margin | 11.37% | -41709.00% (disorted) | Strong |
| Debt/Equity | 0.19 | 0.69 | Strong (Low Leverage) |
| Current Ratio | 1.85 | 10.09 | Neutral |
| ROA | 14.35% | -1504484.00% (disorted) | Strong |
BIRMF outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews BioRem Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
344.41%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
673.13%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
257.55%
Industry Style: Cyclical, Value, Infrastructure
High Growth